XML 86 R12.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Financial Instruments | 12 Months Ended
--- | ---
Jun. 29, 2014
Financial Instruments | Note 4: Financial Instruments Fair Value The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability. A fair value hierarchy has been established that prioritizes the inputs to valuation techniques used to measure fair value. The level of an asset or liability in the hierarchy is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories: Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities with sufficient volume and frequency of transactions. Level 2: Valuations based on observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or model-derived valuations techniques for which all significant inputs are observable in the market or can be corroborated by, observable market data for substantially the full term of the assets or liabilities. Level 3: Valuations based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities and based on non-binding, broker-provided price quotes and may not have been corroborated by observable market data. The following table sets forth the Company’s financial assets and liabilities measured at fair value on a recurring basis:
|  |  |  |  | Fair Value Measurement at June 29, 2014 |
|  | Total |  |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  |  | Significant Other Observable Inputs (Level 2) |  |  | Significant Unobservable Inputs (Level 3) |
|  | (In thousands) |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Short-Term Investments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Money Market Funds |  | $ | 1,168,261 |  |  | $ | 1,168,261 |  |  | $ | — |  |  | $ | — |
Municipal Notes and Bonds |  |  | 335,433 |  |  |  | — |  |  |  | 335,433 |  |  |  | — |
US Treasury and Agencies |  |  | 212,587 |  |  |  | 212,587 |  |  |  | — |  |  |  | — |
Government-Sponsored Enterprises |  |  | 27,692 |  |  |  | — |  |  |  | 27,692 |  |  |  | — |
Foreign Government Bonds |  |  | 35,467 |  |  |  | — |  |  |  | 35,467 |  |  |  | — |
Corporate Notes and Bonds |  |  | 1,008,788 |  |  |  | 132,549 |  |  |  | 876,239 |  |  |  | — |
Mortgage Backed Securities - Residential |  |  | 26,944 |  |  |  | — |  |  |  | 26,944 |  |  |  | — |
Mortgage Backed Securities - Commercial |  |  | 111,933 |  |  |  | — |  |  |  | 111,933 |  |  |  | — |
Total Short-Term Investments |  | $ | 2,927,105 |  |  | $ | 1,513,397 |  |  | $ | 1,413,708 |  |  | $ | — |
Mutual Funds |  |  | 21,758 |  |  |  | 21,758 |  |  |  | — |  |  |  | — |
Derivatives Assets |  |  | 1,592 |  |  |  | — |  |  |  | 1,592 |  |  |  | — |
Total |  | $ | 2,950,455 |  |  | $ | 1,535,155 |  |  | $ | 1,415,300 |  |  | $ | — |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Derivative liabilities |  | $ | 929 |  |  | $ | — |  |  | $ | 923 |  |  | $ | 6 |
The amounts in the table above are reported in the consolidated balance sheet as of June 29, 2014 as follows:
|  | Total |  |  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |
|  | (In thousands) |
Reported As: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash Equivalents |  | $ | 1,173,551 |  |  | $ | 1,168,261 |  |  | $ | 5,290 |  |  | $ | — |
Short-Term Investments |  |  | 1,612,967 |  |  |  | 204,549 |  |  |  | 1,408,418 |  |  |  | — |
Restricted Cash and Investments |  |  | 140,587 |  |  |  | 140,587 |  |  |  | — |  |  |  | — |
Prepaid Expenses and Other Current Assets |  |  | 1,592 |  |  |  | — |  |  |  | 1,592 |  |  |  | — |
Other Assets |  |  | 21,758 |  |  |  | 21,758 |  |  |  | — |  |  |  | — |
Total |  | $ | 2,950,455 |  |  | $ | 1,535,155 |  |  | $ | 1,415,300 |  |  | $ | — |
Accrued Expenses and Other Current Liabilities |  | $ | 923 |  |  | $ | — |  |  | $ | 923 |  |  | $ | — |
Other Non-current Liabilities |  |  | 6 |  |  |  | — |  |  |  | — |  |  |  | 6 |
Total Liabilities |  | $ | 929 |  |  | $ | — |  |  | $ | 923 |  |  | $ | 6 |
The following table sets forth the Company’s financial assets and liabilities measured at fair value on a recurring basis:
|  |  |  |  | Fair Value Measurement at June 30, 2013 |
|  | Total |  |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  |  | Significant Other Observable Inputs (Level 2) |  |  | Significant Unobservable Inputs (Level 3) |
|  | (In thousands) |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Short-Term Investments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Money Market Funds |  | $ | 725,311 |  |  | $ | 725,311 |  |  | $ | — |  |  | $ | — |
Municipal Notes and Bonds |  |  | 268,746 |  |  |  | — |  |  |  | 268,746 |  |  |  | — |
US Treasury and Agencies |  |  | 155,293 |  |  |  | 155,293 |  |  |  | — |  |  |  | — |
Government-Sponsored Enterprises |  |  | 54,805 |  |  |  | — |  |  |  | 54,805 |  |  |  | — |
Foreign Government Bonds |  |  | 24,972 |  |  |  | — |  |  |  | 24,972 |  |  |  | — |
Corporate Notes and Bonds |  |  | 860,492 |  |  |  | 164,885 |  |  |  | 695,607 |  |  |  | — |
Mortgage Backed Securities - Residential |  |  | 27,365 |  |  |  | — |  |  |  | 27,365 |  |  |  | — |
Mortgage Backed Securities - Commercial |  |  | 107,958 |  |  |  | — |  |  |  | 107,958 |  |  |  | — |
Total Short-Term Investments |  | $ | 2,224,942 |  |  | $ | 1,045,489 |  |  | $ | 1,179,453 |  |  | $ | — |
Equities |  |  | 7,096 |  |  |  | 7,096 |  |  |  | — |  |  |  | — |
Mutual Funds |  |  | 18,216 |  |  |  | 18,216 |  |  |  | — |  |  |  | — |
Derivatives Assets |  |  | 4,929 |  |  |  | — |  |  |  | 4,929 |  |  |  | — |
Total |  | $ | 2,255,183 |  |  | $ | 1,070,801 |  |  | $ | 1,184,382 |  |  | $ | — |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Derivative liabilities |  | $ | 1,815 |  |  | $ | — |  |  | $ | 1,620 |  |  | $ | 195 |
The amounts in the table above are reported in the consolidated balance sheet as of June 30, 2013 as follows:
|  | Total |  |  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |
|  | (In thousands) |
Reported As: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash Equivalents |  | $ | 725,311 |  |  | $ | 725,311 |  |  | $ | — |  |  | $ | — |
Short-Term Investments |  |  | 1,334,746 |  |  |  | 155,293 |  |  |  | 1,179,453 |  |  |  | — |
Restricted Cash and Investments |  |  | 164,885 |  |  |  | 164,885 |  |  |  | — |  |  |  | — |
Prepaid Expenses and Other Current Assets |  |  | 4,929 |  |  |  | — |  |  |  | 4,929 |  |  |  | — |
Other Assets |  |  | 25,312 |  |  |  | 25,312 |  |  |  | — |  |  |  | — |
Total |  | $ | 2,255,183 |  |  | $ | 1,070,801 |  |  | $ | 1,184,382 |  |  | $ | — |
Accrued Expenses and Other Current Liabilities |  | $ | 1,620 |  |  | $ | — |  |  | $ | 1,620 |  |  | $ | — |
Other Non-current Liabilities |  |  | 195 |  |  |  | — |  |  |  | — |  |  |  | 195 |
Total Liabilities |  | $ | 1,815 |  |  | $ | — |  |  | $ | 1,620 |  |  | $ | 195 |
The Company’s primary financial instruments include its cash, cash equivalents, short-term investments, restricted cash and investments, long-term investments, accounts receivable, accounts payable, long-term debt and capital leases, and foreign currency related derivatives. The estimated fair value of cash, accounts receivable and accounts payable approximates their carrying value due to the short period of time to their maturities. The estimated fair values of capital lease obligations approximate their carrying value as the substantial majority of these obligations have interest rates that adjust to market rates on a periodic basis. Refer to Note 13 to the Consolidated Financial Statements for additional information regarding the fair value of the Company’s convertible notes. Investments The following tables summarize the Company’s investments (in thousands):
|  | June 29, 2014 |  |  | June 30, 2013 |
|  | Cost |  |  | Unrealized Gain |  |  | Unrealized (Loss) |  |  | Fair Value |  |  | Cost |  |  | Unrealized Gain |  |  | Unrealized (Loss) |  |  | Fair Value |
Cash |  | $ | 285,031 |  |  | $ | — |  |  | $ | — |  |  | $ | 285,031 |  |  | $ | 438,813 |  |  | $ | — |  |  | $ | — |  |  | $ | 438,813 |
Fixed Income Money Market Funds |  |  | 1,168,261 |  |  |  | — |  |  |  | — |  |  |  | 1,168,261 |  |  |  | 725,311 |  |  |  | — |  |  |  | — |  |  |  | 725,311 |
Municipal Notes and Bonds |  |  | 334,329 |  |  |  | 1,108 |  |  |  | (4 | ) |  |  | 335,433 |  |  |  | 268,390 |  |  |  | 805 |  |  |  | (449 | ) |  |  | 268,746 |
US Treasury and Agencies |  |  | 212,436 |  |  |  | 178 |  |  |  | (27 | ) |  |  | 212,587 |  |  |  | 155,648 |  |  |  | 18 |  |  |  | (373 | ) |  |  | 155,293 |
Government-Sponsored Enterprises |  |  | 27,666 |  |  |  | 41 |  |  |  | (15 | ) |  |  | 27,692 |  |  |  | 54,835 |  |  |  | 65 |  |  |  | (95 | ) |  |  | 54,805 |
Foreign Government Bonds |  |  | 35,438 |  |  |  | 57 |  |  |  | (28 | ) |  |  | 35,467 |  |  |  | 24,950 |  |  |  | 47 |  |  |  | (25 | ) |  |  | 24,972 |
Corporate Notes and Bonds |  |  | 1,007,089 |  |  |  | 2,034 |  |  |  | (335 | ) |  |  | 1,008,788 |  |  |  | 861,109 |  |  |  | 1,328 |  |  |  | (1,945 | ) |  |  | 860,492 |
Mortgage Backed Securities - Residential |  |  | 27,067 |  |  |  | 59 |  |  |  | (182 | ) |  |  | 26,944 |  |  |  | 27,618 |  |  |  | 29 |  |  |  | (282 | ) |  |  | 27,365 |
Mortgage Backed Securities - Commercial |  |  | 112,642 |  |  |  | 100 |  |  |  | (809 | ) |  |  | 111,933 |  |  |  | 108,204 |  |  |  | 426 |  |  |  | (672 | ) |  |  | 107,958 |
Total Cash and Short -Term Investments |  | $ | 3,209,959 |  |  | $ | 3,577 |  |  | $ | (1,400 | ) |  | $ | 3,212,136 |  |  | $ | 2,664,878 |  |  | $ | 2,718 |  |  | $ | (3,841 | ) |  | $ | 2,663,755 |
Publicly Traded Equity Securities |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 5,610 |  |  | $ | 1,486 |  |  | $ | — |  |  | $ | 7,096 |
Private Equity Securities |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 5,000 |  |  |  | — |  |  |  | — |  |  |  | 5,000 |
Mutual Funds |  |  | 18,784 |  |  |  | 2,974 |  |  |  | — |  |  |  | 21,758 |  |  |  | 16,611 |  |  |  | 1,619 |  |  |  | (14 | ) |  |  | 18,216 |
Total Financial Instruments |  | $ | 3,228,743 |  |  | $ | 6,551 |  |  | $ | (1,400 | ) |  | $ | 3,233,894 |  |  | $ | 2,692,099 |  |  | $ | 5,823 |  |  | $ | (3,855 | ) |  | $ | 2,694,067 |
As Reported |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and Cash Equivalents |  | $ | 1,452,677 |  |  | $ | — |  |  | $ | — |  |  | $ | 1,452,677 |  |  | $ | 1,162,473 |  |  | $ | — |  |  | $ | — |  |  | $ | 1,162,473 |
Short-Term Investments |  |  | 1,610,790 |  |  |  | 3,577 |  |  |  | (1,400 | ) |  |  | 1,612,967 |  |  |  | 1,335,868 |  |  |  | 2,718 |  |  |  | (3,841 | ) |  |  | 1,334,745 |
Restricted Cash and Investments |  |  | 146,492 |  |  |  | — |  |  |  | — |  |  |  | 146,492 |  |  |  | 166,536 |  |  |  | — |  |  |  | — |  |  |  | 166,536 |
Other Assets |  |  | 18,784 |  |  |  | 2,974 |  |  |  | — |  |  |  | 21,758 |  |  |  | 27,222 |  |  |  | 3,105 |  |  |  | (14 | ) |  |  | 30,313 |
Total |  | $ | 3,228,743 |  |  | $ | 6,551 |  |  | $ | (1,400 | ) |  | $ | 3,233,894 |  |  | $ | 2,692,099 |  |  | $ | 5,823 |  |  | $ | (3,855 | ) |  | $ | 2,694,067 |
The Company accounts for its investment portfolio at fair value. Realized gains (losses) for investment sales are specifically identified. Management assesses the fair value of investments in debt securities that are not actively traded through consideration of interest rates and their impact on the present value of the cash flows to be received from the investments. The Company also considers whether changes in the credit ratings of the issuer could impact the assessment of fair value. Net realized gains (losses) on investments included other-than-temporary impairment charges of $3.7 million, and $1.7 million in fiscal years 2013, and 2012, respectively. There were no other-than-temporary impairment charges in fiscal year 2014. Additionally, gross realized gains/(losses) from sales of investments were approximately $1.5 million and $(2.0) million in fiscal year 2014, $1.6 million and $(1.5) million in fiscal year 2013, and $1.4 million and $(1.0) million in fiscal year 2012, respectively. The following is an analysis of the Company’s fixed income securities in unrealized loss positions (in thousands):
|  | June 29, 2014 |
|  | Unrealized Losses Less Than 12 Months |  |  | Unrealized Losses 12 Months or Greater |  |  | Total |
|  | Fair Value |  |  | Gross Unrealized Loss |  |  | Fair Value |  |  | Gross Unrealized Loss |  |  | Fair Value |  |  | Gross Unrealized Loss |
Fixed Income Securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Municipal Notes and Bonds |  | $ | 5,464 |  |  | $ | (4 | ) |  | $ | — |  |  | $ | — |  |  | $ | 5,464 |  |  | $ | (4 | )
US Treasury and Agencies |  |  | 57,932 |  |  |  | (27 | ) |  |  | — |  |  |  | — |  |  |  | 57,932 |  |  |  | (27 | )
Government-Sponsored Enterprises |  |  | 10,235 |  |  |  | (15 | ) |  |  | — |  |  |  | — |  |  |  | 10,235 |  |  |  | (15 | )
Foregin Government Bonds |  |  | 14,999 |  |  |  | (28 | ) |  |  | — |  |  |  | — |  |  |  | 14,999 |  |  |  | (28 | )
Corporate Notes and Bonds |  |  | 180,834 |  |  |  | (293 | ) |  |  | 6,973 |  |  |  | (42 | ) |  |  | 187,807 |  |  |  | (335 | )
Mortgage Backed Securities - Residential |  |  | 7,993 |  |  |  | (87 | ) |  |  | 7,656 |  |  |  | (95 | ) |  |  | 15,649 |  |  |  | (182 | )
Mortgage Backed Securities - Commercial |  |  | 71,848 |  |  |  | (533 | ) |  |  | 25,316 |  |  |  | (276 | ) |  |  | 97,164 |  |  |  | (809 | )
Total Fixed Income |  | $ | 349,305 |  |  | $ | (987 | ) |  | $ | 39,945 |  |  | $ | (413 | ) |  | $ | 389,250 |  |  | $ | (1,400 | )
The amortized cost and fair value of cash equivalents, short-term investments, and restricted cash and investments with contractual maturities are as follows:
|  | Cost |  |  | Estimated Fair Value |
|  | (in thousands) |
Due in one year or less |  | $ | 1,464,736 |  |  | $ | 1,465,185 |
Due after one year through five years |  |  | 1,146,839 |  |  |  | 1,149,380 |
Due in more than five years |  |  | 313,353 |  |  |  | 312,540 |
|  | $ | 2,924,928 |  |  | $ | 2,927,105 |
Management has the ability, if necessary, to liquidate any of its cash equivalents and short-term investments in order to meet the Company’s liquidity needs in the next 12 months. Accordingly, those investments with contractual maturities greater than one year from the date of purchase nonetheless are classified as short-term on the accompanying Consolidated Balance Sheets. Derivative Instruments and Hedging The Company carries derivative financial instruments (“derivatives”) on its Consolidated Balance Sheets at their fair values. The Company enters into foreign currency forward contracts with financial institutions with the primary objective of reducing volatility of earnings and cash flows related to foreign currency exchange rate fluctuations. The counterparties to these foreign currency forward contracts are large global financial institutions that the Company believes are creditworthy, and therefore, we do not consider the risk of counterparty nonperformance to be material. Cash Flow Hedges The Company’s financial position is routinely subjected to market risk associated with foreign currency exchange rate fluctuations on non-US dollar transactions or cash flows, primarily from Japanese yen-denominated revenues and euro-denominated expenses. The Company’s policy is to mitigate the foreign exchange risk arising from the fluctuations in the value of these non-U.S. dollar denominated transactions or cash flows through a foreign currency cash flow hedging program, using foreign currency forward contracts that generally expire within 12 months and no later than 24 months. These foreign currency forward contracts are designated as cash flow hedges and are carried on the Company’s balance sheet at fair value with the effective portion of the contracts’ gains or losses included in accumulated other comprehensive income (loss) and subsequently recognized in revenue/expense in the same period the hedged items are recognized. At inception and at each quarter end, hedges are tested prospectively and retrospectively for effectiveness using regression analysis. Changes in the fair value of foreign currency forward contracts due to changes in time value are excluded from the assessment of effectiveness and are recognized in revenue in the current period. The change in time value related to these contracts was not material for all reported periods. To qualify for hedge accounting, the hedge relationship must meet criteria relating both to the derivative instrument and the hedged item. These criteria include identification of the hedging instrument, the hedged item, the nature of the risk being hedged and how the hedging instrument’s effectiveness in offsetting the exposure to changes in the hedged item’s fair value or cash flows will be measured. There were no gains or losses during the twelve months ended June 29, 2014 or June 30, 2013 associated with ineffectiveness or forecasted transactions that failed to occur. To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge and the hedges must be tested to demonstrate an expectation of providing highly effective offsetting changes to future cash flows on hedged transactions. When derivative instruments are designated and qualify as effective cash flow hedges, the Company recognizes effective changes in the fair value of the hedging instrument within accumulated other comprehensive income (loss) until the hedged exposure is realized. Consequently, with the exception of excluded time value and hedge ineffectiveness recognized, the Company’s results of operations are not subject to fluctuation as a result of changes in the fair value of the derivative instruments. If hedges are not highly effective or if the Company does not believe that the underlying hedged forecasted transactions will occur, the Company may not be able to account for its derivative instruments as cash flow hedges. If this were to occur, future changes in the fair values of the Company’s derivative instruments would be recognized in earnings. Additionally, related amounts previously recorded in “Other Comprehensive Income” would be reclassified to income immediately. At June 29, 2014, the Company had losses of $0.1 million in accumulated Other Comprehensive Income (“AOCI”), which it expects to reclassify from Other Comprehensive Income into earnings over the next 12 months. Balance Sheet Hedges The Company also enters into foreign currency forward contracts to hedge fluctuations associated with foreign currency denominated monetary assets and liabilities, primarily third party accounts receivables, accounts payables and intercompany receivables and payables. These foreign currency forward contracts are not designated for hedge accounting treatment. Therefore, the change in fair value of these derivatives is recorded as a component of other income (expense) and offsets the change in fair value of the foreign currency denominated assets and liabilities, which are also recorded in other income (expense). As of June 29, 2014, the Company had the following outstanding foreign currency forward contracts that were entered into under its cash flow and balance sheet hedge program:
|  | Derivatives Designated as Hedging Instruments: |  |  | Derivatives Not Designated as Hedging Instruments: |
|  | (in thousands) |
Foreign Currency Forward Contracts |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Buy Contracts |  |  | Sell Contracts |  |  | Buy Contracts |  |  | Sell Contracts |
Japanese Yen |  | $ | — |  |  | $ | 98,501 |  |  | $ | — |  |  | $ | 30,342 |
Swiss Franc |  |  | — |  |  |  | — |  |  |  | 7,023 |  |  |  | — |
Euro |  |  | 93,872 |  |  |  | — |  |  |  | 543 |  |  |  | — |
Korean Won |  |  | — |  |  |  | — |  |  |  | 19,537 |  |  |  | — |
Taiwan Dollar |  |  | — |  |  |  | — |  |  |  | 99,601 |  |  |  | 66,746 |
|  | $ | 93,872 |  |  | $ | 98,501 |  |  | $ | 126,704 |  |  | $ | 97,088 |
The fair value of derivatives instruments in the Company’s consolidated balance sheet as of June 29, 2014 and June 30, 2013 were as follows:
|  | June 29, 2014 |  |  | June 30, 2013 |
|  | Fair Value of Derivative Instruments |  |  | Fair Value of Derivative Instruments |
|  | Asset Derivatives |  |  | Liability Derivatives |  |  | Asset Derivatives |  |  | Liability Derivatives |
|  | Balance Sheet Location |  |  | Fair Value |  |  | Balance Sheet Location |  |  | Fair Value |  |  | Balance Sheet Location |  |  | Fair Value |  |  | Balance Sheet Location |  |  | Fair Value |
|  | (in thousands) |
Derivatives designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign exchange forward contracts |  |  | Prepaid expense and other assets |  |  | $ | 483 |  |  |  | Accrued liabilities |  |  | $ | 805 |  |  |  | Prepaid expense and other assets |  |  | $ | 4,858 |  |  |  | Accrued liabilities |  |  | $ | 1,577 |
Derivatives not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign exchange forward contracts |  |  | Prepaid expense and other assets |  |  |  | 1,109 |  |  |  | Accrued liabilities |  |  |  | 118 |  |  |  | Prepaid expense and other assets |  |  |  | 71 |  |  |  | Accrued liabilities |  |  |  | 43 |
Total derivatives |  |  |  |  |  | $ | 1,592 |  |  |  |  |  |  | $ | 923 |  |  |  |  |  |  | $ | 4,929 |  |  |  |  |  |  | $ | 1,620 |
Under the master agreements with the respective counterparties to our foreign exchange contracts, subject to applicable requirements, we are allowed to net settle transactions of the same currency with a single net amount payable by one party to the other. However, we have elected to present the derivative assets and derivative liabilities on a gross basis in our balance sheet. As of June 29, 2014, the potential effect of rights of set-off associated with the above foreign exchange contracts would be an offset to both assets and liabilities by $0.5 million, resulting in a net derivative asset of $1.1 million. As of June 30, 2013, the potential effect of rights of set-off associated with the above foreign exchange contracts would be an offset to both assets and liabilities by $1.6 million, resulting in a net derivative asset of $3.3 million. We are not required to pledge, nor are we entitled to receive, cash collateral related to these derivative transactions The effect of derivative instruments designated as cash flow hedges, before tax, on the Company’s Consolidated Statements of Operations was as follows:
|  | Twelve Months Ended June 29, 2014 |  |  | Twelve Months Ended June 30, 2013 |
|  | Effective Portion |  |  | Ineffective Portion and Amount Excluded from Effectiveness Testing |  |  | Effective Portion |  |  | Ineffective Portion and Amount Excluded from Effectiveness Testing |
Location of Gain (Loss) Recognized in or Reclassified into Income |  | Gain (Loss) Recognized in AOCI |  |  | Gain (Loss) Reclassified from AOCI into Income |  |  | Gain (Loss) Recognized in Income |  |  | Gain (Loss) Recognized in AOCI |  |  | Gain (Loss) Reclassified from AOCI into Income |  |  | Gain (Loss) Recognized in Income |
|  | (in thousands) |  |  | (in thousands) |
Revenue |  | $ | 7,939 |  |  | $ | 9,027 |  |  | $ | 277 |  |  | $ | 8,322 |  |  | $ | 10,036 |  |  | $ | 376 |
Cost of goods sold |  |  | 812 |  |  |  | 2,393 |  |  |  | (52 | ) |  |  | 2,443 |  |  |  | (1,229 | ) |  |  | (271 | )
Selling, general, and administrative |  |  | 318 |  |  |  | 1,087 |  |  |  | (23 | ) |  |  | 1,154 |  |  |  | (416 | ) |  |  | (130 | )
Other income (expense) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (8 | )
|  | $ | 9,069 |  |  | $ | 12,507 |  |  | $ | 202 |  |  | $ | 11,919 |  |  | $ | 8,391 |  |  | $ | (33 | )
The effect of derivative instruments not designated as cash flow hedges on the Company’s Consolidated Statement of Operations was as follows:
|  |  |  | Twelve Months Ended |
|  |  |  | June 29, 2014 |  |  | June 30, 2013 |
Derivatives Not Designated as Hedging Instruments: |  | Location of Gain (Loss) Recognized in Income |  | Gain Recognized in Income |  |  | Loss Recognized in Income |
|  |  |  | (in thousands) |
Foreign Exchange Contracts |  | Other income (expense) |  | $ | 8,205 |  |  | ($ | 1,585 | )
Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short term investments, restricted cash and investments, trade accounts receivable, and derivative financial instruments used in hedging activities. Cash is placed on deposit in large global financial institutions. Such deposits may be in excess of insured limits. Management believes that the financial institutions that hold the Company’s cash are creditworthy and, accordingly, minimal credit risk exists with respect to these balances. The Company’s over-all portfolio of available-for-sale securities must maintain an average minimum rating of “AA-” or “Aa3” as rated by Standard and Poor’s or Moody’s Investor Services, respectively. To ensure diversification and minimize concentration, the Company’s policy limits the amount of credit exposure with any one financial institution or commercial issuer. The Company is exposed to credit losses in the event of nonperformance by counterparties on the foreign currency forward contracts that are used to mitigate the effect of exchange rate fluctuations and on contracts related to structured share repurchase agreements. These counterparties are large global financial institutions and, to date, no such counterparty has failed to meet its financial obligations to the Company. Credit risk evaluations, including trade references, bank references and Dun & Bradstreet ratings, are performed on all new customers and the Company monitors its customers’ financial statements and payment performance. In general, the Company does not require collateral on sales. As of June 29, 2014, four customers accounted for approximately 15%, 13%, 12% and 12% of accounts receivable. As of June 30, 2013, two customers accounted for approximately 22% and 14% of accounts receivable.

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References No definition available. + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration